A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fasting Condition
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The study was to compare single-dose oral bioavailability of acetaminophen 650 mg extended
release geltabs (containing acetaminophen 650 mg) of OHM Laboratories Inc. (subsidiary of
Ranbaxy Pharmaceuticals Inc., USA) with Tylenol 8 hour extended release gel tabs (containing
acetaminophen 650 mg) of McNeil Consumer & Speciality Pharmaceuticals, U.S.A in healthy,
adult, male human subjects under fasting condition.